Skip to main content
Signal8

Liminatus Pharma, Inc. (LIMN) Form S-1 — Jun 23, 2026

$LIMNForm S-1Filed Jun 23, 2026, 9:28 PM ET0001104659-26-076958Original filing

Liminatus Pharma filed an S-1 registration statement to allow selling stockholder Armistice Capital Master Fund Ltd. to resell up to 20,688,000 shares of common stock. The shares being registered are issuable upon the exercise of inducement warrants, which were issued as part of an agreement where Armistice exercised existing warrants at a reduced price of $0.18 per share.

Key figures

Gross Proceeds
$3,723,840
Offering Price
$0.18
Shares Offered
20,688,000
Shares Outstanding
71,295,633
Net Loss2025
$10.2 million
Accumulated Deficit
$40.0 million
Innocs AIAcquisition Price
$0.20 per share
Innocs AIAcquisition Shares
1,600,000,000

Price after filing

1 day: -7.1%7 days: -10.8%30 days: +9.9%

Close on the filing date to close N calendar days later (from $0.11). Historical, not a forecast.

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.